ArticleFrontiers in neuroscience2025
Nomogram to predict 5-year global cognitive impairment in
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective: Cognitive impairment (CI, combing mild cognitive impairment and dementia) seriously affects the quality of life in patients with Methods: Parkinson's Progression Marker Initiative (PPMI) database was retrieved and PD patients with normal global cognition at baseline were included. These patients were divided into normal cognitive (NC) group and CI group based on their Montreal Cognitive Assessment (MoCA) scores at the 5-year follow-up period. A total of 66 baseline variables were compared between these two groups. Univariate and multivariate logistic regression analyses were conducted, followed by the development and validation of a nomogram to predict 5-year global cognitive decline in Results: A total of 344 PD patients with normal baseline cognition were included, in which 73 individuals developed CI at the 5 year follow-up period. Baseline MoCA, Benton Judgment of Line Orientation (BJOLO), Hopkins Verbal Learning Test (HVLT) immediate recall, Letter Number Sequencing (LNS), Symbol-Digit Modalities Test (SDMT), Semantic Fluency Test (SFT) scores, and Scale for Outcomes in Parkinson's disease for Autonomic symptoms (SCOPA-AUT) total, gastrointestinal, and sexual dysfunction scores were selected out from the 66 potential predictors based on logistic regression analysis. These predictors were finally included in the nomogram of the model. The area under the ROC curve of the model was 0.870 (95% CI, 0.825-0.915). Conclusion: Our study constructed a model that predicts 5-year cognitive decline in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.